Towards Healthcare
Biotechnology Instruments Market Size | Companies | Trends

Biotechnology Instruments Market Size to Touch USD 132.8 Bn by 2033

The report covers Biotechnology Instruments Market Segments and COmpanies Analysis such as Illumina, Inc., Avantor, Inc., Waters Corp., Zeiss Group, Agilent Technologies, Inc., Sartorius AG, Thermo Fisher Scientific, Inc., Shimadzu Corp., Danaher, Mettler Toledo, Bruker Corp., Ori Biotech, PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Eppendorf SE, F. Hoffmann-La Roche AG and Merck. The report offers the value (in USD Billion) for the above segments.

Biotechnology Instruments Market Size and Growth Analysis Report

The global biotechnology instruments market size was estimated at US$ 90.06 billion in 2023 and is projected to grow US$ 132.8 billion by 2033, rising at a compound annual growth rate (CAGR) of 3.96% from 2024 to 2033. The rising research and development in biotechnology, healthcare, and pharmaceutical industries is driving the market’s growth.

Biotechnology Instruments Market Revenue 2023 - 2033

Unlock Infinite Advantages: Subscribe to Annual Membership

Key Takeaways

  • North America dominated the biotechnology instruments market with the largest revenue share of 45% in 2023.
  • Asia Pacific is expected to grow at the fastest CAGR of 5.40% during the forecast period.
  • By product, the analytical instruments segment has held the major revenue share of 63% in 2023.
  • By product, the cell culture instruments segment is projected to grow at a solid CAGR of 10.02% during the forecast period.
  • By end-use, the pharmaceutical & biotechnology companies segment has contributed more than 40% of revenue share in 2023.

Industry at a Glance

The biotechnology instruments market deals with the production and distribution of biotechnology instruments for utilization in the biotechnology, healthcare, and pharmaceutical industries. Several types of equipment are used in biotechnology, depending on the goal of the lab. Research labs for biotechnology are in the vanguard of scientific advancement, continuously stretching the limits of what is practical in disciplines like environmental science, agriculture, and medicine. Some of the most advanced tools and technology available are kept in these labs, enabling scientists to carry out their research and produce ground-breaking findings.

It is crucial for biotech research labs to have the proper equipment, and this cannot be emphasized enough. For doing research, evaluating information, and eventually producing groundbreaking scientific discoveries, this apparatus is essential. Researchers would be unable to perform their tasks precisely or effectively without the required equipment. Furthermore, in the quick-paced field of biotech research, possessing cutting-edge technology might provide a competitive edge and draw in top personnel and possible partners. As a result, the success of every biotech research facility depends on making the correct equipment investments.

Top Companies in the Biotechnology Instruments Market

  • Illumina, Inc.
  • Avantor, Inc.
  • Waters Corp.
  • Zeiss Group
  • Agilent Technologies, Inc.
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.
  • Shimadzu Corp.
  • Danaher
  • Mettler Toledo
  • Bruker Corp.
  • Ori Biotech
  • PerkinElmer, Inc.
  • Bio-Rad Laboratories, Inc.
  • Eppendorf SE
  • F. Hoffmann-La Roche AG
  • Merck

Recent Launch by Merck in the Biotechnology Instruments Market

Company Name Merck
Headquarters New Jersey, U.S.
Pipeline In April 2024, the launch of the Merck Biotechnology Learning Center at Gateway Research Park in Greensboro, North Carolina, was announced today by Merck, which is known as MSD outside of the US and Canada, and North Carolina Agricultural and Technical State University. Modern biopharmaceutical production equipment, a process laboratory, and classroom space are all featured in the 4,025-square-foot Merck Biotechnology Learning Center. Students and Merck trainees can strengthen academic programs and prepare for careers in biotechnology by participating in enhanced research possibilities and hands-on learning at the Learning Center.

Recent Launch in the Biotechnology Instruments Market

Company Name Ori Biotech
Headquarters New Jersey, U.S.
Pipeline In May 2024, Ori Biotech feels it's poised to make a splash in the field of gene and cell therapy, having spent the last five years establishing an automated manufacturing platform. The IRO platform, a manufacturing technology developed by Ori with cost and space efficiency in mind, was unveiled on Wednesday. The technology, according to the business, may move between projects at different phases of development because of its flexibility.

Advanced Technologies Drive the Biotechnology Instruments Market

Additionally, cutting-edge technologies exist that can significantly improve biotech research. Among these are next-generation sequencing (NGS) instruments, which have completely changed the way researchers examine DNA and RNA. Deeper knowledge of genetic variants and gene expression is made possible by the fast sequencing of millions of DNA fragments at once by NGS equipment. A further illustration is the gene editing technology CRISPR-Cas9, which has created new avenues for genetic engineering and the treatment of illness. Through the provision of in-depth molecular analysis and data processing, other cutting-edge technologies such as mass spectrometry, microfluidics, and bioinformatics software also play crucial roles in biotech research.

Continuous Maintenance is a Restraint for the Biotechnology Instruments Market’s Growth

Since even a small failure might interfere with studies and produce unreliable findings, regular maintenance plans should be created to guarantee that all equipment is operating at peak performance, parts must be replaced as needed, and the area must be cleaned and calibrated during this procedure. It requires time and training to assign a specific individual or team to maintain the equipment. Equipment upkeep requires significant financial and material resources.

Robotics and Automation Creates Opportunity for the Biotechnology Instruments Market

The use of robots and automation in laboratory operations is one subject that has attracted a lot of attention lately. Thanks to these developments, tests may be conducted without human assistance around the clock and with more efficiency and fewer mistakes. Furthermore, we should anticipate seeing more ecologically friendly lab procedures and equipment created as the need for sustainable practices grows. The focus of biotech research lab equipment in the future will be on sustainability and innovation, from energy-efficient machinery to biodegradable materials.

Report Highlight

Product Insights

By product, the analytical instruments segment held the largest biotechnology instruments market share in 2023. The biotech business encompasses a multitude of vocations. Analytical tools used in biotechnology labs are among them. Finally, there is a machine that is responsible for examining samples of live organisms, including RNA, proteins, cells, and DNA. These tools help in the development of novel medical procedures and medications as well as research and analysis of gene function. These devices are critical. Their advancement in medicine and the ability to cure the most complicated human problems makes biotech experts possible. Your industrial processes and system will profit from the many advantages of implementing analytical instruments. Ensuring constant quality and minimizing mistakes, an analytical instrument offers precise and accurate readings.

For instance,

  • In September 2023, a leading global provider of clinical diagnostic tools and life science research, Bio-Rad Laboratories, Inc., introduced two new products: the PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers. They were created to facilitate the use of PCR in process development, quality control, and basic and translational research. The newest models in Bio-Rad's line of traditional PCR heat cyclers are the PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers.

By product, the cell culture instruments segment is expected to grow at the fastest rate during 2024-2033. A few essential pieces of equipment and some basic reagents are needed in order to undertake basic cell culture protocols and conduct research involving cell culture operations. Probably the most crucial piece of equipment for cell culture is a biosafety cabinet, also known as a laminar flow hood. When used properly, it shields the user from aerosols and offers a clean working environment for the product.

For cell cultures to flourish, an environment that is tightly regulated is necessary. Incubators for cell cultures are widely used to consistently and carefully supply the ideal growth conditions, including temperature, humidity, and CO2 levels. From basic dishes and slides to systems for cultivating and tracking cultures, all cultures require certain tools and materials. Fittings and consumables are needed for fermenters and bioreactors. Grid templates and colony counts come in very handy for monitoring developing cultures. Cells can be grown in a well-equipped cell culture facility for use in pharmaceutical development, biological research, or the production of medications and vaccines.

For instance,

  • In February 2024, for usage in healthcare facilities, academic institutions, and pharmaceutical enterprises, a new model in the PHCbi brand VIP® ECO SMART ultra-low temperature (ULT) freezer line was introduced. The PHCbi brand of cell preservation and growth products is supplied to the North American and Latin American markets by PHC Corporation of North America (PHCNA). The first dual-voltage ULT freezer under the PHCbi brand is the MDF-DU703VHA-PA. With the multi-award-winning VIP ECO SMART series' enhanced security and energy-saving capabilities, labs may now switch between 115V and 220V power sources.

End-use Insights

By end-use, the pharmaceutical & biotechnology companies segment dominated the biotechnology instruments market in 2023. While particular equipment may differ from region to region, some equipment is universally utilized in laboratories for biotechnology and pharmaceuticals. These include centrifuges, incubators, laminar airflow, hot air ovens, microscopes, analyzers, shakers, mixers, autoclaves, thermocyclers, electrophoresis machines, PCR machines, and a variety of other equipment. Examine every secondhand biotechnology lab equipment available, such as tablets and food testing devices. This apparatus is used for the development and testing of pharmaceuticals and other medical supplies. In addition, equipment is required for ongoing development and research, as well as tests involving cell culture and biomolecules.

Regional Insights

By region, North America dominated the biotechnology instruments market in 2023. Because of variables such as the growing number of biotechnology research-related activities and the rising incidence of chronic illnesses in the area, North America is anticipated to have a sizable market share in the analyzed industry. Furthermore, it is anticipated that the strategic actions and presence of major market competitors in this area would quicken the rate of market expansion. Furthermore, it is anticipated that the strategic actions and presence of major market competitors in this area would quicken the rate of market expansion. The two major countries that contribute to the growth of the biotechnology instruments market in the region are the U.S. and Canada.

As per the FAO's estimation, an additional 60% of food must be produced by 2050 in order to sustain the 9.3 billion people that inhabit the planet. Food needs to be plentiful and nourishing. Poor nutrition is a major cause of sickness in the United States, accounting for 600,000 deaths annually and raising the risk of heart disease, diabetes, and obesity. In addition, it has wider effects, such as increased healthcare expenses and lost productivity. An estimated 48 million illnesses and 3,000 fatalities are attributed to foodborne diseases in the U.S. annually. Biotechnology and biomanufacturing have the potential to enhance productivity and promote the creation of sustainable food sources such as new crops and protein sources. These sources can complement the present food system and aid in ensuring that all people have equal access to wholesome meals.

By region, Asia Pacific is expected to grow at the fastest rate during the forecast period. It is anticipated that the Asia-Pacific region will see a significant increase in biotechnology research due to advancements in clinical trial services, government policies that are supportive of the field, and epidemiological considerations. Particular emphasis areas include photoproductivity, thermodynamics, microbial biotechnology, nanoparticles and bioengineering, microfluidic devices and superhydrophobicity, micro and long non-coding RNA, molecular and cell biology, and crop science. India, China, Japan, and South Korea are majorly contributing to the growth of the biotechnology instruments market in the APAC region.

Rapid technical breakthroughs and an increasing focus on domestic innovation are driving the laboratory and analytical instrument business in India toward a revolutionary path. Online and at-line testing, cloud computing, artificial intelligence, machine learning, big data analytics, and process analytical technologies are bringing together cutting-edge technology, and this is why the sector is ready for rapid development and expansion. Within the laboratory equipment and analytical instrument area, there are increasing prospects for domestic companies. Industry experts have explored the challenges, opportunities, and methods for promoting innovation and competitiveness in this dynamic biotechnology instruments market. Now, let's investigate deeper. Due to India's leadership in biotechnology, pharmaceuticals, and healthcare, the country's laboratory and analytical equipment business has experienced rapid expansion in recent years.

For instance,

  • In December 2023, the third edition of Global Bio-India, a massive international biotechnology gathering held at Bharat Mandapam, Pragati Maidan in New Delhi from December 4–6, 2023, featured the launch of 14 new biotech-based products developed by startups and entrepreneurs across verticals including healthcare, diagnostics, medical devices, agriculture, and industrial biotechnology. The Biotechnology Industry Research Assistance Council (BIRAC) and the Department of Biotechnology (DBT) jointly released this news.

Recent Developments in the Biotechnology Instruments Market

  • In May 2024, MEPSGEN, a Korean company that specializes in the development of innovative microfluidic technologies for nanomedicine, will be present at the 2024 BIO International Convention, which will be held in San Diego, California, from June 3–6. The business intends to display technology, including the automated organ tissue culture system ProMEPS, which was introduced in November of last year, and the forthcoming NanoCalibur, which is scheduled for release in the middle of the year as a nanoparticle production system.
  • In November 2023, Transasia added five more jewels to its already impressive crown during the just-ended 40th National Conference of the Association of Clinical Biochemists of India (ACBICON), as well as the 62nd Annual Conference of IAPM & Annual Conference of IAP-ID! During the two conferences, Transasia unveiled the five newest and most technologically advanced equipment.
  • In May 2023, at the BIO-IT World Conference, Benchling, the R&D Cloud driving the biotechnology sector, announced an effort to standardize instrument data conversion throughout the scientific community. There are two things the firm is doing: As a proactive participant in the Allotrope Foundation Partner Network (APN), Benchling continues to advance industry standards while developing a collection of free and open-source converters that transform data generated by instruments into the Allotrope Simple Model (ASM) format, which enables organizations to implement these standards.

Segments Covered in the Report

By Product

  • Analytical Instruments
    • Polymerase Chain Reaction
    • Spectroscopy
    • Microscopy
    • Chromatography
    • Flow Cytometry
    • Sequencing
    • Microarray
    • Others
  • Cell Culture Instruments
    • Culture Systems
    • Incubators
    • Cryostorage Equipment
    • Biosafety Equipment
    • Pipetting Instruments
  • Cell Separation Instruments
    • Centrifuge
    • Filtration Systems
    • Magnetic-activated Cell Separator Systems
  • Immunoassay Instruments
  • Clinical Chemistry Analyzers
  • Others

By End-use

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Laboratories
  • Academic & Research Institutes
  • Others

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500

About The Author

Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.


Genetic engineering and tissue culture are the two primary methods employed in biotechnology.

The main goal of biology instrumentation or bioinstrumentation, is to bridge the gap between the medical and engineering domains.

USDA, Department of Biotechnology, National Institutes of Health, U.S. Department of State, National Science Foundation.